Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James O. Armitage currently holds 146,974 shares of Cardiff Oncology, Inc. (CRDF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James O. Armitage has been a net seller of CRDF stock. They have purchased $144.0K and sold $1.2M worth of shares.
James O. Armitage's most recent insider trade was on Jun 27, 2024, when they sold 29,700 shares at $0.00 per share.
James O. Armitage serves as Executive at Cardiff Oncology, Inc. (CRDF). They have executed 10 insider transactions totaling $1.3M over their tenure at the company.
James O. Armitage holds the position of Executive at Cardiff Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
James O. Armitage has shown a selling trading pattern, with $144.0K in total purchases and $1.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James O. Armitage was on Sep 18, 2017, when they sold $675.3K worth of TSRO shares. This transaction involved 5,743 shares at $117.58 per share.
James O. Armitage currently owns 146,974 shares of Cardiff Oncology, Inc. (CRDF), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James O. Armitage's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James O. Armitage has 10 Form 4 filings on record as an insider at Cardiff Oncology, Inc..
Set alerts for James O. Armitage and 40,000+ other insiders.